Rubedo Life Sciences says its skin cream RLS-1496 cleared senescent cells, boosted collagen 10%, and reduced skin age in a ...

Anavex Life Sciences will proceed with a clinical study of a new drug to treat the genetic disorder Fragile X syndrome after getting clearance from U.S. regulators. The company said the Food and Drug ...

Inc., a privately held clinical-stage biopharmaceutical company developing next-generation therapies for retinal diseases, today announced positive topline results from its BETTIS-1 Phase 2 clinical ...

US officials canceled NASA’s ambitious Mars Sample Return program, leaving potential evidence of ancient life sitting on Mars ...

The ultimate goal when adopting AI tools should be to reduce friction while keeping clinical and operational judgment at the ...

How to deal with 'unknown words'The 2027 Common Test for University Admissions will be held on January 16 (Sat) and 17 (Sun), ...

Nordic Pharma, Inc., a subsidiary of SEVER Life Sciences B.V., will feature LACRIFILL® Canalicular Gel, a novel therapy for ocular surface control, during the American Academy of Ophthalmology Annual ...

Briya, developer of AIRE, the scientific AI platform turning fragmented healthcare data into defensible evidence, today ...

IQVIA launches Life Science Models to help predict clinical trial outcomes, optimise study design and identify development ...

Hepion Pharmaceuticals completes the Gravitas Life Sciences acquisition, creating a three-program portfolio across therapeutics and diagnostics.

Mounting research links repeated head trauma in professional sports to lasting brain injury, with few effective treatment options for retired athletes ...

On August 19, 2026, a research team at Oregon Health & Science University (OHSU) published a follow-up study in the medical journal JAMA Network Open involving 346 people who utilized Oregon's legal ...